Boston Trust Walden’s Versum Materials, Inc. VSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-5,793
| Closed | -$307K | – | 387 |
|
|
2019
Q3 | $307K | Sell |
5,793
-325
| -5% | -$16.9K | ﹤0.01% | 347 |
|
|
2019
Q2 | $316K | Sell |
6,118
-1,425
| -19% | -$73.5K | ﹤0.01% | 347 |
|
|
2019
Q1 | $379K | Sell |
7,543
-435
| -5% | -$17.3K | 0.01% | 347 |
|
|
2018
Q4 | $221K | Sell |
7,978
-1,423
| -15% | -$45K | ﹤0.01% | 363 |
|
|
2018
Q3 | $339K | Sell |
9,401
-90
| -0.9% | -$3.39K | ﹤0.01% | 353 |
|
|
2018
Q2 | $353K | Sell |
9,491
-392
| -4% | -$15K | 0.01% | 350 |
|
|
2018
Q1 | $372K | Sell |
9,883
-2,377
| -19% | -$90.5K | 0.01% | 352 |
|
|
2017
Q4 | $464K | Sell |
12,260
-11,174
| -48% | -$436K | 0.01% | 339 |
|
|
2017
Q3 | $910K | Sell |
23,434
-743
| -3% | -$26.6K | 0.01% | 308 |
|
|
2017
Q2 | $786K | Sell |
24,177
-17,360
| -42% | -$542K | 0.01% | 306 |
|
|
2017
Q1 | $1.27M | Sell |
41,537
-24,157
| -37% | -$705K | 0.02% | 292 |
|
|
2016
Q4 | $1.84M | Buy |
+65,694
| New | +$1.64M | 0.03% | 270 |
|
Boston Trust Walden's VSM Position: Q4 2019 in Review
Boston Trust Walden sold out of Versum Materials, Inc. (VSM) in Q4 2019, closing a stake of 5,793 shares — an estimated $307K sold.
Boston Trust Walden first reported a position in VSM in Q4 2016 and held it in 12 quarters. The position peaked at $1.84M in Q4 2016. 0 funds tracked by Wall St. Rank hold VSM as of Q4 2019.
- Boston Trust Walden reported no remaining Versum Materials, Inc. position as of Q4 2019 after selling out during the quarter.
- Boston Trust Walden sold 5,793 Versum Materials, Inc. shares in Q4 2019, an estimated $307K.
- Boston Trust Walden first reported a position in Versum Materials, Inc. in Q4 2016 and held it in 12 quarters.
- Boston Trust Walden's Versum Materials, Inc. position peaked at $1.84M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Versum Materials, Inc. as of Q4 2019.
Based on Boston Trust Walden's 13F filing for Q4 2019, filed 10 Jan 2020.